Literature DB >> 3518490

Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT.

C Cobelli, G Pacini, G Toffolo, L Saccà.   

Abstract

The "minimal model" of glucose disappearance provides noninvasive estimates of insulin sensitivity and glucose effectiveness from an intravenous glucose tolerance test (IVGTT). However, this model does not allow the separation of glucose production from utilization. To overcome this limitation, labeled glucose was injected along with cold glucose in six normal dogs, and both cold and labeled glucose time courses were monitored along with insulin concentration. A revised minimal model was fitted to tracer data to obtain new measures of insulin sensitivity (SI* = 6.41 +/- 0.91 10(-4) min-1 X microU-1 X ml-1) and fractional glucose clearance (SG* = 0.0092 +/- 0.0009 min-1). SG* was compared with a direct measure obtained by a hepatic arterial-venous difference technique, which yielded a value of 0.0097 +/- 0.0002, virtually identical to SG*, thereby validating the model estimate. When the original minimal model was identified from cold data, we obtained S1 = 4.52 +/- 1.39 and SG = 0.042 +/- 0.009. SI* and SG* were different from SI and SG, respectively. In particular SG overestimates fractional glucose clearance by approximately five times. The revised minimal model yields glucose disposal parameters SI* and SG* that are not affected by the confounding effect of insulin and glucose inhibition of glucose production. Limitations inherent in cold IVGTT and original minimal model are overcome by labeled IVGTT and the revised minimal model, while test simplicity remains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518490     DOI: 10.1152/ajpendo.1986.250.5.E591

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

1.  Effect of acitretin on the response to an intravenous glucose tolerance test in healthy volunteers.

Authors:  D Hartmann; I Forgo; U C Dubach; U Hennes
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Use of labeled oral minimal model to measure hepatic insulin sensitivity.

Authors:  Chiara Dalla Man; Gianna Toffolo; Rita Basu; Robert A Rizza; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-02       Impact factor: 4.310

3.  Is the minimal model too minimal?

Authors:  A Caumo; P Vicini; C Cobelli
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

4.  Dynamic modeling of exercise effects on plasma glucose and insulin levels.

Authors:  Anirban Roy; Robert S Parker
Journal:  J Diabetes Sci Technol       Date:  2007-05

5.  Physical activity-the major unaccounted impediment to closed loop control.

Authors:  Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2008-01

6.  Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamics.

Authors:  L L Ng; T D Hockaday
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

7.  Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Authors:  Thomas F Lotz; J Geoffrey Chase; Kirsten A McAuley; Geoffrey M Shaw; Paul D Docherty; Juliet E Berkeley; Sheila M Williams; Christopher E Hann; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 8.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes.

Authors:  S B Bowes; T R Hennessy; A M Umpleby; J J Benn; N C Jackson; M A Boroujerdi; P H Sönksen; C Lowy
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

10.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.